Slide 1: Q2 2024 Supplemental Financial Information
August 6, 2024 Q2 2024 Supplemental Financial Information
Slide 2: Use of Non-GAAP Financial Measures
Use of Non-GAAP Financial Measures Inogen has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three and six months ended June 30, 2024 and June 30, 2023. Management believes that non-GAAP financial measures, taken in conjunction with U.S. GAA
Slide 3: Q2 2024 Results: Revenue by region and category
Q2 2024 Results Revenue by region and category Total by Category Q2 Revenue Year-Over-Year Change % of Total Revenue Business-to-business $21.3 million 16.5% 24.0% domestic sales Business-to-business $30.5 million 31.1% 34.4% international sales Direct-to-consumer $22.6 million (15.6)% 25.4% domesti
Slide 4: Operating Expense and Net Loss
Operating Expense and Net Loss (in thousands) Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Operating expense Research and development $ 5,616 $ 4,293 $ 12,194 $ 9,637 Sales and marketing 25,617 26,906 52,553 55,347 General and administrative 18,568 14,613 35,699 33,476 T
Slide 5: Reconciliation of GAAP to Non-GAAP: Adjusted EBITDA
Reconciliation of GAAP to Non-GAAP Adjusted EBITDA (in thousands) Three months ended Six months ended June 30, June 30, Non-GAAP EBITDA and Adjusted EBITDA 2024 2023 2024 2023 Net loss (GAAP) $ (5,590) $ (9,826) $ (20,168) $ (30,175) Non-GAAP adjustments: Interest income, net (1,333) (1,646) (2,736)
Slide 6: Reconciliation of GAAP to Non-GAAP: Adjusted Net Loss
Reconciliation of GAAP to Non-GAAP Adjusted Net Loss (in thousands) Three months ended June 30, Net Loss Diluted EPS Non-GAAP Adjusted Net Loss and Diluted EPS 2024 2023 2024 2023 Financial Results (GAAP) $ (5,590) $ (9,826) $ (0.24) $ (0.42) Non-GAAP adjustments: Amortization of intangibles 1,188 5
Slide 7: Stock-Based Compensation
Stock-Based Compensation (in thousands) Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Stock-based compensation expense by type of award: Restricted stock units and restricted stock awards $ 1,696 $ 3,177 $ 4,005 $ 6,482 Employee stock purchase plan 118 86 225 223 Total st
Slide 8: Improving lives through respiratory care
Improving lives through respiratory care